Skip to content
Home » Clinifer Co., Ltd. Clinifer has signed a sponsorship agreement with CyberAgent Legit, a professional dance team from CyberAgent.

Clinifer Co., Ltd. Clinifer has signed a sponsorship agreement with CyberAgent Legit, a professional dance team from CyberAgent.

[Clinifer Co., Ltd.] Clinifer has signed a sponsorship agreement with CyberAgent Legit, a professional dance team from CyberAgent. *Clinifer Co., Ltd.*
Press release: July 5, 2024
**
Clinifer signs a sponsorship agreement with CyberAgent’s professional dance team “CyberAgent Legit”
* Clinifer Co., Ltd. (Headquarters: Chuo-ku, Osaka, Representative: Kohei Toda) is a subsidiary of CyberAgent Co., Ltd. (Headquarters: Shibuya-ku, Tokyo, Representative Director: Fujita)
We would like to inform you that we have signed a sponsorship contract with the professional dance team “CyberAgent Legit” from Jin. *

Breaking will become a new event at the Paris Olympic Games, which will begin in July 2024, and dancing is attracting attention. Clinifer Co., Ltd. has a management philosophy of “smoothing the distribution of pharmaceuticals,” and continues to take on challenges as a company that brings about changes in pharmaceutical distribution not only in Japan but around the world. “CyberAgent
I sympathized with the way that “Legit” continues to take on challenges and the way the team works together to achieve results, which led to this sponsorship agreement. Through this agreement, “CyberAgent” continues to challenge not only Japan but also the world. We support “Legit”.
* About “CyberAgent Legit” *
“Become a dance team that represents the 21st century” “CyberAgent Legit” brings together members who are active in dance contests and battles around the world. Specializes in various genres such as street dance HIPHOP, POP, LOCK, BREAKING, CHOREOGRAPHY, etc.
The team name “CyberAgent Legit” was chosen from the idea of ​​delivering “Legit=authentic, high-quality” dance.
Their skillful dance, which shows off the best teamwork in the league, has garnered the support of many fans, and has been featured in “D.LEAGUE 22-23 SEASON” and “D.LEAGUE
23-24 SEASON” has a track record of winning “REGULAR SEASON” and “Championship runner-up” for two consecutive years.
In addition, in January 2024, the British audition program “BRITAIN’S GOT TALENT SERIES”
17″ and won the Golden Buzzer. He is expanding his range of challenges not only in Japan but also overseas.
D League official page “CyberAgent Legit” https://home.dleague.co.jp/teams/t0m9/

*Comment from our representative (Kohei Toda, President and CEO of Clinifer Co., Ltd.)*
With this sponsorship agreement, we hope to be able to contribute to Japanese dance culture, even if only in a small way.
Since our company is a BtoB pharmaceutical business, we are not well known by the general public, but we would be happy if many people who love dance would take this opportunity to get to know our name.

*About Clinifer Co., Ltd.*
Founded in 2017. We are an innovative company specializing in the pharmaceutical industry that uses the power of IT to change the form of global pharmaceutical distribution for the better, based on the belief of “smoothing the distribution of pharmaceuticals.” With Kosei Pharmaceutical Co., Ltd., a pharmaceutical wholesaler founded in 1952, under our umbrella, we will provide new solutions through the fusion of pharmaceuticals and IT.

【Company Profile】
Company name: Clinifer Co., Ltd.
Head office location: 1-12 Higashikoraibashi, Chuo-ku, Osaka City, Osaka Prefecture
Representative Director: Kohei Toda
Established: January 13, 2017
Business details: Domestic pharmaceutical EC platform business, international pharmaceutical EC platform business, venture investment business
・Domestic EC platform for medical drugs “Kosei Market” (https://kosei.com/) ・Overseas medical drug EC platform “synapse” (https://synapse.inc/)

Homepage URL: https://cliniphar.com/
Group company: Kosei Pharmaceutical Co., Ltd. (https://koseipharma.com/)

[Contact information for this press release]
Clinifer Co., Ltd. Person in charge: Matsumoto
TEL: 06-6941-9288
E-mail: info●cliniphar.com *● is @ (at mark).
*About details about this release*
https://prtimes.jp/main/html/rd/p/000000005.000087862.html





Copyright © PR TIMES Corporation All Rights Reserved.